Nucleic Acid Tech The company specializes in Nucleic Acid Programmable Protein Arrays (NAPPA) and positions itself as a leader in translational proteomics, presenting a clear opportunity to connect with pharmaceutical and biotech firms seeking advanced protein microarrays for drug development, diagnostics, and personalized medicine.

Academic Ties Co-founders are prominent academics from Arizona State University, signaling strong research credibility and potential for collaboration with university labs, grant programs, and technology transfer offices seeking partnered R&D or pilot studies.

Early Stage, High Impact With a very small team and revenue under one million, there is room to position Ordinatrix as a strategic outsourced R&D partner for proteomics services, offering scalable engagements for biotech startups and mid‑size pharma exploring proteomics capabilities.

IP and Quality Focus Emphasis on intellectual property and high-quality, flexible, precise protein arrays suggests opportunities to pitch licensing discussions, custom array development, and technology enablement within risk‑sharing or milestone‑driven agreements.

Digital and Global Reach Existing tech stack including WordPress, Shopify, and JSON‑LD indicates an online outreach strategy; leverage digital marketing, content campaigns, and developer/academic outreach to generate inbound interest from life sciences buyers globally.